Hypertrophy in nonfacial scars can be caused by mechanical stress created by large core muscles and joint movement and by increased pressure and shear over sites with boney prominences. Careful surgical planning and technique to minimize wound tension, followed by tension off-loading, can help minimize scar hypertrophy. Both surgical and nonsurgical techniques can be utilized for non-facial scar revision. The adoption of a combination therapy with multiple treatment modalities may be required to improve the appearance of nonfacial scars.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12788/j.sder.2015.0167 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patient-Reported Outcomes of Medical Tattooing for Capillary Malformations.
Dermatology
October 2023
Plastic, Reconstructive and Hand Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.
Background: Patients with capillary malformations (CMs) may undergo medical tattooing (MT) as an alternative to laser therapy. But little is known about treatment results and impact from the patients' perspective.
Objectives: In this cross-sectional digital survey study, we evaluated the patient-reported outcomes of MT for CMs.
Sequential Use of CO Laser Prior to Nd:YAG and Dye Laser in the Management of Non-Facial Warts: A Retrospective Study.
Medicina (Kaunas)
January 2022
Department of Systems Medicine, Tor Vergata University, 00173 Rome, Italy.
: Warts are benign lesions of viral etiology characterized by a hyperkeratotic appearance tending to spread across the skin surface. Various treatments have been proposed to manage this condition, such as acids, imiquimod, photodynamic therapy, cryotherapy, and various lasers. In this paper, we describe a combination protocol using CO laser prior to Nd:YAG laser for lesions interesting the palmoplantar areas or dye laser for lesions on other skin surfaces in the management of non-facial warts resistant to traditional therapies.
View Article and Find Full Text PDFBackground: Fractional laser treatment was introduced in 2004 as a non-invasive technique to treat sun-damaged and aging skin. Since then, numerous ablative and non-ablative photothermolysis technologies and devices have been introduced, increasing the options for clinicians and patients but also increasing the complexity regarding which system to use and the techniques to optimize outcomes. No two devices are the same and the user-manuals preset dosimetry does not address many clinical situations, which can create confusion for new and inexperienced users.
View Article and Find Full Text PDFTreatment of facial and non-facial lentigines with a 730 nm picosecond titanium: Sapphire laser is safe and effective.
Lasers Surg Med
January 2022
Candela Medical, Marlborough, Massachusetts, USA.
Objective: A 730 nm picosecond-domain laser was developed to improve the clearance of pigmented lesion and reduce adverse events. This study assessed the safety and efficacy of this system for the clearance of lentigines and explores how the short picosecond pulses interact with tissue via histology.
Study Design And Methods: Twenty subjects with Fitzpatrick skin types II-IV were enrolled in this prospective, IRB-approved study.
Comparison between cutaneous leishmaniasis patients with facial and non-facial lesions.
Int J Dermatol
September 2021
Soroka University Medical Center, Beer-Sheva, Israel.
Background: We compared demographic, clinical, treatment, and outcome characteristics of facial cutaneous leishmaniasis (CL) and non-facial CL.
Methods: In this retrospective cohort study, polymerase chain reaction confirmed Leishmania major CL patients with ≥2 documented hospital visits, 2014-2019, were included.
Results: Overall, 134 patients (34% and 66% with facial and non-facial CL, respectively) were included.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!